期刊文献+

下调血管内皮细胞蛋白激酶CK2表达对血管增殖影响的体外研究

In vitro study of the effect of Casein Kinase2 siRNA on anginogesis
原文传递
导出
摘要 目的探究蛋白激酶CK2表达下调对血管内皮细胞形成新生血管的能力以及对其细胞中血管内皮生长因子(VEGF)表达的影响。方法化学合成siRNA转染人脐静脉内皮细胞(HUVECs),用RT-PCR法和Western blotting法检测细胞转染效率;MTT法检测CK2表达下调对HUVECs细胞增殖的影响;成管实验和划痕实验检测CK2表达下调对细胞成管、迁移的影响;Real-time PCR和Western blotting法检测siRNA干扰蛋白激酶CK2表达后VEGF m RNA及蛋白的表达。结果 si RNA干扰蛋白激酶CK2达到了预期干扰率75%,蛋白激酶CK2表达下调后抑制了HUVECs增殖、成管、迁移(P<0.05),也抑制了VEGF m RNA及蛋白的表达。结论蛋白激酶CK2表达下调可抑制VEGF的表达及HUVECs的增殖、成管、迁移。 Objective To prove the effect of Casein Kinase2 siRNA on vascular endothelial growth factor(VEGF) expression and the angiogenic capacity in human umbilical vein endothelial cells (HUVECs).Methods HUVECs were transfected with either Casein Kinase2 siRNA or negative control siRNA.Cell proliferation was analyzed by MTT assay;the angiogenic capacity was accessed by tube formation;cell migration was assessed by the wound-healing mod-el.Gene and protein expressions of VEGF were examined by Real-time PCR and Western blotting methods.Results Casein Kinase2 siRNA decreased the expressions of Casein Kinase2 and declined HUVEC proliferation,tube formation and migration.It was also reduced the expression of VEGF mRNA and VEGF protein.Conclusion Our results dem-onstrated that Casein Kinase2 siRNA reduced the expression of VEGF and declined the capacity of angiogenesis in HU-VECs.
出处 《山东大学耳鼻喉眼学报》 CAS 2015年第3期76-80,83,共6页 Journal of Otolaryngology and Ophthalmology of Shandong University
关键词 蛋白激酶 CK2 血管内皮细胞 视网膜新生血管 血管内皮生长因子 siRNA siRNA Vascular endothelial cells Angiogenesis Vascular endothelial growth factor
  • 相关文献

参考文献14

  • 1Campochiaro P A. Ocular neovascularization[J]. J Mol Med (Berl), 2013, 91(3):311-321.
  • 2Dorrell M, Uusitalo-Jarvinen H, Aguilar E, et al. Ocular neovascularization: basic mechanisms and therapeutic advances[J]. Surv Ophthalmol, 2007, 52(1):3-19.
  • 3Andrei A. Expression of protein kinase CK2 in astroglial cells of normal and neovascularized retina[J]. Am J Pathol, 2006, 168(5):1722-1736.
  • 4Kramerov A A, Ljubimov A V. Focus on molecules:protein kinase CK2[J]. Exp Eye Res, 2012, 8(101):111-112.
  • 5Barnstable C J, Tombran-Tink J. Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential[J]. Prog Retin Eye Res, 2004, 23(5):561-577.
  • 6Hou J, Lin L, Zhou W, et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals mir-199ab-3p as therapeutic target for hepatocellular carcinoma[J].Cancer Cell, 2011, 19(2):232-243.
  • 7Ren Shancheng, Liu Yawei. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer[J]. J Urol, 2013, 190(6):2278-2287.
  • 8Duncan J S, Litchfield D W. Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2[J]. Biochim Biophys Acta, 2008, 1784(1):33-47.
  • 9Dorrell M I, Aguilar E, Scheppke L, et al . Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis[J]. Proc Natl Acad Sci USA, 2007, 104(3):967-972.
  • 10Maloney S C, Godeiro K D, Odashiro A N, et al. Current and emerging concepts in the management of neovascular age-related macular degeneration[J]. Cardiovasc Hematol Agents Med Chem, 2007, 5(2):147-154.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部